Literature DB >> 22201870

Bladder tumors and aromatic amines - historical milestones from Ludwig Rehn to Wilhelm Hueper.

Holger Georg Dietrich1, Klaus Golka.   

Abstract

We know today that environmental factors must be regarded as a significant cause of the urinary bladder carcinoma. In Germany, the urinary bladder carcinoma is the second most common urological tumor among men and the most common among women and more than 100 occupational bladder cases are recognized and compensated per year. Scientific studies of this problem reach back to the 18th century. However it was only in 1895 that the surgeon Ludwig Rehn firstly described 3 cases of occupational bladder tumors in at most 45 fuchsine workers in Frankfurt / M. This extremely significant discovery was followed by a description of a large number of cases of urinary bladder tumors among workers in the paint industry. Nevertheless, it was impossible to induce bladder cancer in animals by aromatic amines for many years. In the 1930s, the pathologist Wilhelm C. Hueper was the first to induce bladder cancer in animal experiments, applying beta-naphthylamine to dogs. Based on these experiments and corroborated by epidemiologic studies, beta-naphthylamine was banned in Germany and many countries from the 1950s on. This review will highlight work and life of these two pioneering medical researchers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201870     DOI: 10.2741/375

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  2 in total

1.  [From "Karzinos" to modern urologic oncology : A long way from the first surgical procedures to targeted therapy].

Authors:  J Konert
Journal:  Urologe A       Date:  2016-08       Impact factor: 0.639

2.  Bladder cancer: a simple model becomes complex.

Authors:  Giovanni Battista Di Pierro; Caterina Gulia; Cristiano Cristini; Giorgio Fraietta; Lorenzo Marini; Pietro Grande; Vincenzo Gentile; Roberto Piergentili
Journal:  Curr Genomics       Date:  2012-08       Impact factor: 2.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.